Sheep constitute one of Iraq’s most numerous livestock populations, and their milk is marketed both raw and in processed dairy products. Mastitis is the principal mammary disease affecting ewes; however, published Iraqi evidence concerning its bacterial aetiology has not been systematically consolidated. This structured narrative review examines the microbial causes, epidemiology, pathogenicity, antimicrobial resistance, diagnostic approaches, and treatment of ovine mastitis in Iraq. Relevant publications were sought in PubMed/PMC, Scopus, Web of Science, Google Scholar, the Directory of Open Access Journals, and the Iraqi Academic Scientific Journals portal, with reference-list screening for publications available before October 2026. Iraqi studies report clinical mastitis in approximately 2–7% and subclinical mastitis in approximately 12–26% of examined ewes, udder halves, or milk samples, although these denominators are not directly interchangeable. Coagulase-negative staphylococci, particularly Staphylococcus epidermidis, frequently predominate in subclinical infections. In clinical and gangrenous mastitis, S. aureus is a major pathogen; it was also detected in 23.3% of subclinical milk samples examined in Nineveh. Additional reported agents include Escherichia coli, Proteus mirabilis, Streptococcus agalactiae, S. dysgalactiae, S. uberis, Mannheimia haemolytica, Pseudomonas aeruginosa, Histophilus ovis, and Mycoplasma agalactiae. Staphylococcal and Enterobacteriaceae-associated mastitis are linked to markedly elevated milk-whey lactate dehydrogenase, alkaline phosphatase, and aspartate aminotransferase activities. Molecular investigations identified clfA, clfB, coa, and mecA in ovine S. aureus, while some coagulase-negative variants lacked coa. Extended-spectrum β-lactamase-producing E. coli carrying blaCTX-M were isolated from the milk and faeces of ewes and lambs and frequently showed co-resistance to tetracycline, ciprofloxacin, and trimethoprim–sulfamethoxazole. Overall, staphylococci account for an important share of reported ovine mastitis in Iraq, alongside emerging antimicrobial-resistance concerns. Geographical coverage, definitions, and laboratory methods remain inconsistent. Priorities include standardized multi-governorate surveillance, phenotypic confirmation of methicillin resistance, toxin-gene profiling, responsible antimicrobial use, and feasible improvements in milking hygiene.